Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Monoclonal Antibody Therapeutics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Naked, Fusion Protein, Antibody Fragment, Conjugate, Multi-specific)
5.2.2. By Application (Cancer, Autoimmune Diseases, Infectious Diseases, Others)
5.2.3. By Production Source (Human, Humanized, Chimeric, Others)
5.2.4. By End User (Hospital, Specialty Centers, Research Institutes)
5.2.5. By Region
5.2.6. By Company (Shares of Top 5 Market Players)
5.3. Market Map
5.3.1. By Product Type
5.3.2. By Application
5.3.3. By Production Source
5.3.4. By End User
5.3.5. By Region
6. North America Monoclonal Antibody Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Application
6.2.3. By Production Source
6.2.4. By End User
6.2.5. By Country
6.2.5.1. United States Monoclonal Antibody Therapeutics Market Outlook
6.2.5.1.1. Market Size & Forecast
6.2.5.1.1.1. By Value
6.2.5.1.2. Market Share & Forecast
6.2.5.1.2.1. By Product Type
6.2.5.1.2.2. By Application
6.2.5.1.2.3. By Production Source
6.2.5.1.2.4. By End User
6.2.5.2. Canada Monoclonal Antibody Therapeutics Market Outlook
6.2.5.2.1. Market Size & Forecast
6.2.5.2.1.1. By Value
6.2.5.2.2. Market Share & Forecast
6.2.5.2.2.1. By Product Type
6.2.5.2.2.2. By Application
6.2.5.2.2.3. By Production Source
6.2.5.2.2.4. By End User
6.2.5.3. Mexico Monoclonal Antibody Therapeutics Market Outlook
6.2.5.3.1. Market Size & Forecast
6.2.5.3.1.1. By Value
6.2.5.3.2. Market Share & Forecast
6.2.5.3.2.1. By Product Type
6.2.5.3.2.2. By Application
6.2.5.3.2.3. By Production Source
6.2.5.3.2.4. By End User
7. Europe Monoclonal Antibody Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By Production Source
7.2.4. By End User
7.2.5. By Country
7.2.5.1. France Monoclonal Antibody Therapeutics Market Outlook
7.2.5.1.1. Market Size & Forecast
7.2.5.1.1.1. By Value
7.2.5.1.2. Market Share & Forecast
7.2.5.1.2.1. By Product Type
7.2.5.1.2.2. By Application
7.2.5.1.2.3. By Production Source
7.2.5.1.2.4. By End User
7.2.5.2. Germany Monoclonal Antibody Therapeutics Market Outlook
7.2.5.2.1. Market Size & Forecast
7.2.5.2.1.1. By Value
7.2.5.2.2. Market Share & Forecast
7.2.5.2.2.1. By Product Type
7.2.5.2.2.2. By Application
7.2.5.2.2.3. By Production Source
7.2.5.2.2.4. By End User
7.2.5.3. United Kingdom Monoclonal Antibody Therapeutics Market Outlook
7.2.5.3.1. Market Size & Forecast
7.2.5.3.1.1. By Value
7.2.5.3.2. Market Share & Forecast
7.2.5.3.2.1. By Product Type
7.2.5.3.2.2. By Application
7.2.5.3.2.3. By Production Source
7.2.5.3.2.4. By End User
7.2.5.4. Italy Monoclonal Antibody Therapeutics Market Outlook
7.2.5.4.1. Market Size & Forecast
7.2.5.4.1.1. By Value
7.2.5.4.2. Market Share & Forecast
7.2.5.4.2.1. By Product Type
7.2.5.4.2.2. By Application
7.2.5.4.2.3. By Production Source
7.2.5.4.2.4. By End User
7.2.5.5. Spain Monoclonal Antibody Therapeutics Market Outlook
7.2.5.5.1. Market Size & Forecast
7.2.5.5.1.1. By Value
7.2.5.5.2. Market Share & Forecast
7.2.5.5.2.1. By Product Type
7.2.5.5.2.2. By Application
7.2.5.5.2.3. By Production Source
7.2.5.5.2.4. By End User
8. Asia Pacific Monoclonal Antibody Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By Production Source
8.2.4. By End User
8.2.5. By Country
8.2.5.1. China Monoclonal Antibody Therapeutics Market Outlook
8.2.5.1.1. Market Size & Forecast
8.2.5.1.1.1. By Value
8.2.5.1.2. Market Share & Forecast
8.2.5.1.2.1. By Product Type
8.2.5.1.2.2. By Application
8.2.5.1.2.3. By Production Source
8.2.5.1.2.4. By End User
8.2.5.2. India Monoclonal Antibody Therapeutics Market Outlook
8.2.5.2.1. Market Size & Forecast
8.2.5.2.1.1. By Value
8.2.5.2.2. Market Share & Forecast
8.2.5.2.2.1. By Product Type
8.2.5.2.2.2. By Application
8.2.5.2.2.3. By Production Source
8.2.5.2.2.4. By End User
8.2.5.3. South Korea Monoclonal Antibody Therapeutics Market Outlook
8.2.5.3.1. Market Size & Forecast
8.2.5.3.1.1. By Value
8.2.5.3.2. Market Share & Forecast
8.2.5.3.2.1. By Product Type
8.2.5.3.2.2. By Application
8.2.5.3.2.3. By Production Source
8.2.5.3.2.4. By End User
8.2.5.4. Japan Monoclonal Antibody Therapeutics Market Outlook
8.2.5.4.1. Market Size & Forecast
8.2.5.4.1.1. By Value
8.2.5.4.2. Market Share & Forecast
8.2.5.4.2.1. By Product Type
8.2.5.4.2.2. By Application
8.2.5.4.2.3. By Production Source
8.2.5.4.2.4. By End User
8.2.5.5. Australia Monoclonal Antibody Therapeutics Market Outlook
8.2.5.5.1. Market Size & Forecast
8.2.5.5.1.1. By Value
8.2.5.5.2. Market Share & Forecast
8.2.5.5.2.1. By Product Type
8.2.5.5.2.2. By Application
8.2.5.5.2.3. By Production Source
8.2.5.5.2.4. By End User
9. South America Monoclonal Antibody Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Application
9.2.3. By Production Source
9.2.4. By End User
9.2.5. By Country
9.2.5.1. Brazil Monoclonal Antibody Therapeutics Market Outlook
9.2.5.1.1. Market Size & Forecast
9.2.5.1.1.1. By Value
9.2.5.1.2. Market Share & Forecast
9.2.5.1.2.1. By Product Type
9.2.5.1.2.2. By Application
9.2.5.1.2.3. By Production Source
9.2.5.1.2.4. By End User
9.2.5.2. Argentina Monoclonal Antibody Therapeutics Market Outlook
9.2.5.2.1. Market Size & Forecast
9.2.5.2.1.1. By Value
9.2.5.2.2. Market Share & Forecast
9.2.5.2.2.1. By Product Type
9.2.5.2.2.2. By Application
9.2.5.2.2.3. By Production Source
9.2.5.2.2.4. By End User
9.2.5.3. Colombia Monoclonal Antibody Therapeutics Market Outlook
9.2.5.3.1. Market Size & Forecast
9.2.5.3.1.1. By Value
9.2.5.3.2. Market Share & Forecast
9.2.5.3.2.1. By Product Type
9.2.5.3.2.2. By Application
9.2.5.3.2.3. By Production Source
9.2.5.3.2.4. By End User
10. Middle East & Africa Monoclonal Antibody Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Application
10.2.3. By Production Source
10.2.4. By End User
10.2.5. By Country
10.2.5.1. South Africa Monoclonal Antibody Therapeutics Market Outlook
10.2.5.1.1. Market Size & Forecast
10.2.5.1.1.1. By Value
10.2.5.1.2. Market Share & Forecast
10.2.5.1.2.1. By Product Type
10.2.5.1.2.2. By Application
10.2.5.1.2.3. By Production Source
10.2.5.1.2.4. By End User
10.2.5.2. Saudi Arabia Monoclonal Antibody Therapeutics Market Outlook
10.2.5.2.1. Market Size & Forecast
10.2.5.2.1.1. By Value
10.2.5.2.2. Market Share & Forecast
10.2.5.2.2.1. By Product Type
10.2.5.2.2.2. By Application
10.2.5.2.2.3. By Production Source
10.2.5.2.2.4. By End User
10.2.5.3. UAE Monoclonal Antibody Therapeutics Market Outlook
10.2.5.3.1. Market Size & Forecast
10.2.5.3.1.1. By Value
10.2.5.3.2. Market Share & Forecast
10.2.5.3.2.1. By Product Type
10.2.5.3.2.2. By Application
10.2.5.3.2.3. By Production Source
10.2.5.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Technology Launches
13. Competitive Landscape
13.1. F. Hoffmann-La Roche ltd
13.1.1. Business Overview
13.1.2. Patient Offerings
13.1.3. Recent Developments
13.1.4. Key Personnel
13.1.5. SWOT Analysis
13.2. Novartis AG
13.3. Merck & Co. Inc.
13.4. Pfizer Inc.
13.5. Eli Lilly and Co. (Lilly)
13.6. Sanofi S.A
13.7. AstraZeneca inc.
13.8. Bayer AG
13.9. Regeneron Pharmaceuticals Inc.
13.10. GSK Plc
14. Strategic Recommendations
About us & Disclaimer